Corporate News
- Cell MedX Corp. Announces a Non-Brokered Private Placement Financing April 17, 2020
- Cell MedX Corp. Receives Quality Management System ISO 13485:2016 Certificate for the eBalance® Device April 7, 2020
- Cell MedX Corp. Reacquires World Wide Exclusivity Rights for the eBalanceⓇ Device January 30, 2020
- Cell MedX Corp. Engages Dr. Peter Eppinga as Lead Investigator in the eBalance R&D Experience Study December 12, 2019
- Cell MedX Corp. Receives eBalance Trademark October 17, 2019
- Cell MedX Corp. Provides Corporate Update September 12, 2019
- CELL MEDX CORP. ISSUES CLARIFYING RELEASE REGARDING THE BULL REPORT ARTICLE September 10, 2019
- Cell MedX Corp. (CMXC) Receives Approval to Commence Family Practice (BC) Observational Study August 19, 2019
- Cell MedX Corp. (CMXC) Closes the First Tranche of its Non-brokered Private Placement Financing June 28, 2019
- Cell MedX Corp. (CMXC) Engages Think Ink Marketing June 21, 2019
Historical Press Releases
This website contains historical and archived press releases for Cell MedX Corp. The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, Cell MedX Corp and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.